AAM
ELV icon

Ardevora Asset Management’s Elevance Health ELV Stock Holding History

Ardevora Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-81,206
Closed -$36.1M – 123
2023
Q2 		$36.1M Buy
81,206
+26,161
+48% +$12.1M 0.87% 51
2023
Q1 		$25.3M Buy
55,045
+7,128
+15% +$3.39M 0.45% 97
2022
Q4 		$24.6M Sell
47,917
-50,792
-51% -$25.8M 0.42% 99
2022
Q3 		$44.8M Sell
98,709
-16,300
-14% -$7.8M 0.81% 60
2022
Q2 		$55.5M Buy
+115,009
New +$56.9M 0.91% 33

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ardevora Asset Management's ELV Position: Q3 2023 in Review

Ardevora Asset Management sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 81,206 shares — an estimated $36.1M sold.

Ardevora Asset Management first reported a position in ELV in Q2 2022 and held it in 5 quarters. The position peaked at $55.5M in Q2 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Ardevora Asset Management reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Ardevora Asset Management sold 81,206 Elevance Health shares in Q3 2023, an estimated $36.1M.
  • Ardevora Asset Management first reported a position in Elevance Health in Q2 2022 and held it in 5 quarters.
  • Ardevora Asset Management's Elevance Health position peaked at $55.5M in Q2 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Ardevora Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.